Arecor Therapeutics plc (LON:AREC – Get Free Report) hit a new 52-week low on Thursday . The company traded as low as GBX 50 ($0.63) and last traded at GBX 50 ($0.63), with a volume of 50543 shares changing hands. The stock had previously closed at GBX 51.50 ($0.65).
Arecor Therapeutics Trading Down 2.9 %
The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51. The firm’s 50-day simple moving average is GBX 60.66 and its 200-day simple moving average is GBX 70.56. The firm has a market capitalization of £18.88 million, a PE ratio of -1.77 and a beta of -0.18.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
See Also
- Five stocks we like better than Arecor Therapeutics
- Most Volatile Stocks, What Investors Need to Know
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- The Role Economic Reports Play in a Successful Investment Strategy
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- What Are Dividends? Buy the Best Dividend Stocks
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
